Company Overview and News

Winnebago (WGO) Gains on Towable Unit, High Debt Level a Woe

2018-03-26 zacks
On Mar 23, we issued an updated research report on Winnebago Industries, Inc. (WGO - Free Report) .

Winnebago (WGO) Q2 Earnings Lag Estimates, Revenues Top

2018-03-22 zacks
Winnebago Industries Inc. (WGO - Free Report) registered adjusted earnings of 62 cents per share in the second quarter of fiscal 2018 (ended Feb 24, 2018), missing the Zacks Consensus Estimate of 65 cents. In the year-ago period, earnings were 48 cents per share. However, net income soared 44.6% to $22.1 million.

Winnebago Industries' (WGO) CEO Michael Happe on Q2 2018 Results - Earnings Call Transcript

2018-03-21 seekingalpha
Good day, ladies and gentlemen, and welcome to the Winnebago Second Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer-session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call is being recorded.

Is Winnebago (WGO) Stock a Solid Choice Right Now?

2018-03-21 zacks
One stock that might be an intriguing choice for investors right now is Winnebago Industries, Inc. (WGO - Free Report) . This is because this security in the Building Products - Mobile Homes and RV Builders space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board.

Winnebago Industries Announces Record Second Quarter Fiscal 2018 Results

2018-03-21 globenewswire
-- Quarterly Revenues Increased 26% Over Prior Year on Continued Strong Towable Segment Growth -- -- Quarterly Diluted EPS of $0.69, Up 44% Over Prior Year -- -- Gross Margins Increased 110 Basis Points Over Prior Year --

Camping World Holdings: The Right Stock At The Right Time

2018-03-20 seekingalpha
The market has not been kind to Camping World Holdings (NYSE: CWH) as of late. Since hitting a high of $47.40 on December 8th, CWH shareholders have seen their investment drop to the tune of 28%. Let's take a closer look and see if there is a valid reason for the pullback or if the recent pullback presents a buying opportunity.

Malibu Boats - Torque And Tailwind

2018-03-20 seekingalpha
Malibu Boats is a manufacturer and marketer of inboard, sterndrive and outboard powerboats, as well as boat accessories and trailers.

Here’s What Equities Analysts Are Saying About Trump’s Tariffs - Bloomberg

2018-03-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Looking For Action? S&P 1500 Most Volatile Stocks

2018-02-15 seekingalpha
For traders with a short-term time horizon looking for big moves, we have updated our list of the S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread between the intraday high and low over the last 50 days). The stocks are grouped based on whether they have a rising or falling 50-day moving average (DMA).

WGO / Winnebago Industries, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A (Passive Investment)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No. 1)*       WINNEBAGO INDUSTRIES (Name of Issuer)   Common Stock (Title of Class of Securities)     974637100                                 (CUSIP Number)                                   December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 974637100